scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.HUMPATH.2014.01.022 |
P698 | PubMed publication ID | 24767772 |
P50 | author | Scott B Halstead | Q60059357 |
Sanya Sukpanichnant | Q70279607 | ||
Somchai Thiemmeca | Q102215396 | ||
Prida Malasit | Q114399357 | ||
P2093 | author name string | Aroonroong Suttitheptumrong | |
Komgrid Charngkaew | |||
Kyaw Moe | |||
Khin Saw Aye | |||
Nuntaya Punyadee | |||
Ne Win | |||
Kyaw Zin Wai | |||
P2860 | cites work | The global distribution and burden of dengue | Q24628768 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Myanmar | Q836 |
autopsy | Q41482 | ||
Dengue virus | Q476209 | ||
dengue hemorrhagic fever | Q18554268 | ||
P304 | page(s) | 1221-1233 | |
P577 | publication date | 2014-02-20 | |
P1433 | published in | Human Pathology | Q15756731 |
P1476 | title | Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar | |
P478 | volume | 45 |
Q30250993 | 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response |
Q24276108 | A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease |
Q51336360 | A systematic approach to the development of a safe live attenuated Zika vaccine. |
Q33750037 | Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease |
Q91212064 | Adaptive immune responses to primary and secondary dengue virus infections |
Q26700094 | Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity |
Q59354500 | Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors |
Q29365355 | Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies |
Q30588465 | Cellular visualization of macrophage pyroptosis and interleukin-1β release in a viral hemorrhagic infection in zebrafish larvae |
Q92106605 | Cutaneous Dengue Virus Inoculation Triggers Strong B Cell Reactions but Contrastingly Poor T Cell Responses |
Q33425879 | Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection |
Q34722528 | Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity |
Q39371396 | Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement |
Q40128790 | Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)-10 by monocytes. |
Q28577861 | Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses |
Q35050760 | Dengue and its effects on liver |
Q47166741 | Dengue hemorrhagic fever complicated with acute liver failure: a case report |
Q42996339 | Dengue infection. |
Q90286486 | Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies |
Q40140017 | Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination |
Q92675561 | Dengue virus and the complement alternative pathway |
Q38732727 | Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission |
Q52671501 | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. |
Q38887040 | Early dengue virus interactions: the role of dendritic cells during infection |
Q66678806 | Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation |
Q38272173 | Endothelial dysfunction in dengue virus pathology |
Q40126576 | Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil |
Q35535146 | Germinal center reaction following cutaneous dengue virus infection in immune-competent mice |
Q40066511 | HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. |
Q60043900 | Heart and liver are infected in fatal cases of dengue: three PCR based case studies |
Q33679954 | Hypoxia enhances antibody-dependent dengue virus infection |
Q91962220 | Insight into the Tropism of Dengue Virus in Humans |
Q90462841 | Insights from direct studies on human dengue infections |
Q40038877 | Intrahost Selection Pressures Drive Rapid Dengue Virus Microevolution in Acute Human Infections |
Q58796349 | Lessons learnt from managing a case of dengue hemorrhagic fever complicated with acute liver failure and acute kidney injury: a case report |
Q38775951 | Mass spectrometric analysis of host cell proteins interacting with dengue virus nonstructural protein 1 in dengue virus-infected HepG2 cells. |
Q33430984 | Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage |
Q64099350 | MicroRNA profiling of mouse liver in response to DENV-1 infection by deep sequencing |
Q34991385 | Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection |
Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
Q115250601 | Monocytes as suitable carriers for dissemination of dengue viral infection |
Q24276139 | Mouse models of dengue virus infection for vaccine testing |
Q57454669 | Nonalcoholic fatty liver disease is associated with increased hemoconcentration, thrombocytopenia, and longer hospital stay in dengue-infected patients with plasma leakage |
Q26766198 | Pathogenesis of Dengue: Dawn of a New Era |
Q39258872 | Pathogenesis of vascular leak in dengue virus infection |
Q27312219 | Patterns and causes of liver involvement in acute dengue infection |
Q35043739 | Platelet activating factor contributes to vascular leak in acute dengue infection |
Q30145665 | Postmortem Findings for 7 Neonates with Congenital Zika Virus Infection |
Q28550953 | Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection |
Q45324746 | RNAi screen reveals a role of SPHK2 in dengue virus-mediated apoptosis in hepatic cell lines |
Q92859173 | Recent advances in understanding dengue |
Q59790650 | Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection |
Q26700056 | The Cellular Bases of Antibody Responses during Dengue Virus Infection |
Q59356038 | The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis |
Q46966557 | The burden of dengue, source reduction measures, and serotype patterns in Myanmar, 2011 to 2015-R2. |
Q58582556 | The monocyte-macrophage-mast cell axis in dengue pathogenesis |
Q90238787 | Ultrastructural Features of Human Liver Specimens from Patients Who Died of Dengue Hemorrhagic Fever |
Q40165652 | Virus-specific T lymphocytes home to the skin during natural dengue infection |
Search more.